Allergan Inc (AGN)

AGN (NYSE:Drugs) EQUITY
$240.22
pos +2.88
+1.21%
Today's Range: 237.72 - 241.78 | AGN Avg Daily Volume: 2,195,100
Last Update: 03/16/15 - 4:03 PM EDT
Volume: 7,503,601
YTD Performance: 13.00%
Open: $238.89
Previous Close: $237.34
52 Week Range: $115.94 - $237.88
Oustanding Shares: 300,237,694
Market Cap: 72,123,098,853
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 3 4 4
Moderate Buy 0 0 0 0
Hold 11 11 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.47 2.57 2.43 2.43
Latest Dividend: 0.05
Latest Dividend Yield: 0.08%
Dividend Ex-Date: 02/25/15
Price Earnings Ratio: 47.18
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
47.18 47.90 27.68
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
16.75% 87.17% 158.30%
GROWTH 12 Mo 3 Yr CAGR
Revenue 14.90 0.34 0.10
Net Income 54.60 0.63 0.18
EPS 54.60 0.67 0.18
Earnings for AGN:
EBITDA 2.49B
Revenue 7.24B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $1.79 $2.14 $8.58 $10.45
Number of Analysts 4 4 13 11
High Estimate $1.84 $2.20 $8.86 $11.65
Low Estimate $1.76 $2.11 $8.33 $9.91
Prior Year $1.18 $1.51 $6.65 $8.58
Growth Rate (Year over Year) 51.69% 41.89% 29.08% 21.75%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Don't get me started ... wait, DO get me started.
These companies are the hottest thing going.
Combined Heinz-Kraft heads a long second-quarter list.
It's almost comical how welcoming it is these days.
It is no pipedream that the stock could trade to $240.
The two apparent failures are in fact opportunities.
Bearish
Jan 08, 2015 | 7:41 AM EST
AGN was downgraded from Buy to Neutral, BTIG said. Do not expect another takeover bid to materialize. 
Has the pharmaceutical company really changed its strategy?
An immense market rotation is happening.
This market provides a slew of reasons to buy right now.

Columnist Conversations

A "mega car merger" is being discussed on Fast Money tonite. The shares are trading up in after hours trading....
All better than expected!!
Hope you'll join me for a bigtime webinar after the close today, we'll be talkin' markets and stuff. https://a...
McIlroy shoots 80 in fist round of the Irish Open. http://espn.go.com/golf/story/_/id/12967211/rory-mcilroy-da...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.